Showing 2991-3000 of 18629 results for "".
Endeavors of the Heart: Leveraging Innovative Technologies for Transcatheter Therapies
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/endeavors-of-the-heart-leveraging-innovative-technologies-for-transcatheter-therapies/10779/Open-heart surgery used to be the only option, but now, there’s a new player in the field that’s become the procedure of choice.Impacts of Prolonged Screen Time on Children's Health
https://reachmd.com/programs/everyday-family-medicine/impacts-of-prolonged-screen-time-on-childrens-health/10166/Are your pediatric patients addicted to their screens? Know the symptoms to look out for.Investing in Cures for Multiple Sclerosis
https://reachmd.com/programs/clinicians-roundtable/investing-in-cures-for-multiple-sclerosis/3602/Through a venture philanthropy called Fast Forward, LLC the National Multiple Sclerosis Society plans to deploy 1.5 to 2 million dollars in the next 18 months as seed funding to biotech companies on the path towards cures for Multiple Sclerosis. Our guest, Timothy Coetzee executive director of FastPI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.The Impact of ECTRIMS Over 40 Years
https://reachmd.com/programs/neurofrontiers/the-impact-of-ectrims-over-40-years/26378/Hear from Dr. Mar Tintoré on what to expect from this year’s ECTRIMS conference.Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
https://reachmd.com/programs/cme/Comprehensive-Biomarker-Testing-in-mBC-Informs-Clinical-Decision-Making/37332/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
https://reachmd.com/programs/project-oncology/unresectable-hepatocellular-carcinoma-care-investigating-a-combination-therapy/32994/Here’s a look into clinical trial findings on envafolimab-lenvatinib combination therapy for the management of unresectable hepatocellular carcinoma.How Artificial Intelligence Is Changing the Practice of Gastroenterology
https://reachmd.com/programs/gi-insights/how-artificial-intelligence-is-changing-the-practice-of-gastroenterology/18107/Explore the use of AI in diagnosing a variety of gastroenterological conditions, like Barrett’s esophagus, gastric cancer, colon polyps, and more.Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
https://reachmd.com/programs/neurofrontiers/investigating-the-clinical-utility-of-the-multiple-sclerosis-disease-activity-test/16250/Tune in to hear how a multiprotein blood test is being used by clinicians to detect and measure disease activity in patients with MS.The Impact of Positive Communication with PsA Patients
https://reachmd.com/programs/beyond-skin-deep/the-impact-of-positive-communication-with-psa-patients/10148/As physicians, we know that there are risks and benefits to all medical treatments, but how do we convey this to our PsA patients?